Nirmala Sitharaman’s Biopharma SHAKTI announcement in the Union Budget has worked as a booster for the biotechnology sector that was…
World Health Organisation’s former and first chief scientist Dr Soumya Swaminathan sees the in-house strengthening of CDSCO’s scientific skills and…
Union Budget 2026–27 prioritises healthcare with medical tourism hubs, Rs 10,000 crore Biopharma Shakti, cheaper cancer drugs, new mental health…
From diabetes and obesity to cancer and rare diseases, the India–EU Free Trade Agreement could lower drug prices by up…
Union Budget 2026 expectations, recommendations, and key focus on green infrastructure, taxation, defence, and retail sectors.
Discover 5 major healthcare changes expected in Budget 2026, including cheaper meds and new tax rules—see what industry experts recommend.
The Seoul Pavilion at CES 2026 had 19 institutions, including nine major universities, four districts in Seoul, and six startup…
A Lancet study found that paracetamol does not affect a child’s intellectual development if ingested during pregnancy. Find more here.
According to industry bodies, the government should consider offering globally competitive R&D incentives and fiscal support for clinical research to…
Billionaire Elon Musk has criticised a Canadian hospital after the death of a 44-year-old Indian-origin man who was allegedly made…
Sun Pharma-owned Taro Pharmaceutical is recalling over 17,000 units of antifungal Ciclopirox Shampoo in the US due to manufacturing-related quality…
The year 2025 has been a significant one for the Indian pharmaceutical sector. It witnessed several novel launches, collaborations, digital…
Fortis Healthcare, through its subsidiary International Hospital Limited, has acquired People Tree Hospital in Bengaluru for Rs 430 crore.
Centre’s ambitious Ayushman Bharat healthcare scheme is facing a gap between rules and reality. What are the challenges, and how…
Explore Kotak MF’s 2026 outlook: double-digit earnings and key sectors set to drive India’s market growth. Read more for insights!
Two lesser-known small-cap stocks with solid returns on capital employed and Zero debt, just saw their promoter holdings grow more…
While the bluechips and big names hog all the limelight in media, two recently listed smallcap underdogs are silently delivering…
Ayushman Bharat–Pradhan Mantri Jan Arogya Yojana (PM-JAY) provides ₹5 lakh annual health cover on a family floater basis, and now…